Cure51
FranceEntry
2024
Hold
2yr
Status
Active
Who owns Cure51?
Cure51 is currently owned by Hitachi Ventures through Hitachi Ventures Fund III (2023 vintage), since 2024. Across its history, Cure51 has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Hitachi VenturesHitachi Ventures Fund III · 2023 · VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2024 · present
Sofinnova PartnersActive
2024 · present(2yr) · Sofinnova Digital Medicine I · 2022 · VC
Hitachi VenturesActive
2024 · present(2yr) · Hitachi Ventures Fund III · 2023 · VC
More from Hitachi Ventures Fund III
Other portfolio companies in the same fund.
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Cure51
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Cure51?
0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Cure51.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue